Press release
Eosinophilic Gastroenteritis Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | Novartis, Allakos, AstraZeneca, Pfizer, Regeneron, Celgene
To Know in detail about the Eosinophilic Gastroenteritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Eosinophilic Gastroenteritis Market Forecast
https://www.delveinsight.com/sample-request/eosinophilic-gastroenteritis-ege-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Eosinophilic Gastroenteritis Market Report:
• The Eosinophilic Gastroenteritis market size was valued approximately USD 78 Million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• More than 31,000 cases of Eosinophilic Gastroenteritis were reported in the US in 2021, but only about 2,800 cases were reported in Spain
• In the United States in 2021, there were approximately 16,500 males and 15,000 females who had eosinophilic gastroenteritis. By 2032, the prevalence is anticipated to rise
• In 2021, Germany had the most common incidence of eosinophilic gastroenteritis among the EU5 nations (about 4,400 cases)
• Key Eosinophilic Gastroenteritis Companies: Allakos, AstraZeneca, Invea Therapeutics, Pfizer, Ception Therapeutics, Regeneron, EsoCap AG, Celgene, Allakos Inc., Ellodi Pharma, Takeda, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Novartis, EMS, Celgene, Oxagen Ltd, and others
• Key Eosinophilic Gastroenteritis Therapies: Lirentelimab, Benralizumab, INVA8001, Etrasimod, reslizumab, Dupilumab, ESO-101, CC-93538, AK002, APT-1011, budesonide, Mesalamine, IRL201104, QAX576, Florence 30 μg/mL, RPC4046, OC000459, and others
• The Eosinophilic Gastroenteritis epidemiology based on gender analyzed that Eosinophilic Gastroenteritis shows slight predominance in males than females in the US. However, in eosinophilic esophagitis (EoE), there is no male predominance
• The Eosinophilic Gastroenteritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Eosinophilic Gastroenteritis pipeline products will significantly revolutionize the Eosinophilic Gastroenteritis market dynamics.
Eosinophilic Gastroenteritis Overview
The triad of eosinophilic infiltration of specific gastrointestinal tract segments, abnormalities of gastrointestinal function (ranging from dyspepsia and obstruction to diarrhoea and ascites), and the exclusion of other diseases with peripheral eosinophilia characterise Eosinophilic Gastroenteritis (EGE), a rare digestive disease.
Get a Free sample for the Eosinophilic Gastroenteritis Market Report
https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Eosinophilic Gastroenteritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Eosinophilic Gastroenteritis Epidemiology Segmentation:
The Eosinophilic Gastroenteritis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Eosinophilic Gastroenteritis
• Prevalent Cases of Eosinophilic Gastroenteritis by severity
• Gender-specific Prevalence of Eosinophilic Gastroenteritis
• Diagnosed Cases of Episodic and Chronic Eosinophilic Gastroenteritis
Download the report to understand which factors are driving Eosinophilic Gastroenteritis epidemiology trends @ Eosinophilic Gastroenteritis Epidemiology Forecast
https://www.delveinsight.com/sample-request/eosinophilic-gastroenteritis-ege-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Eosinophilic Gastroenteritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Eosinophilic Gastroenteritis market or expected to get launched during the study period. The analysis covers Eosinophilic Gastroenteritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Eosinophilic Gastroenteritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Eosinophilic Gastroenteritis Therapies and Key Companies
• Lirentelimab: Allakos
• Benralizumab: AstraZeneca
• INVA8001: Invea Therapeutics
• Etrasimod: Pfizer
• reslizumab: Ception Therapeutics
• Dupilumab: Regeneron
• ESO-101: EsoCap AG
• CC-93538: Celgene
• AK002: Allakos Inc.
• APT-1011: Ellodi Pharma
• budesonide: Takeda
• Mesalamine: Dr. Falk Pharma GmbH
• IRL201104: Revolo Biotherapeutics
• QAX576: Novartis
• Florence 30 μg/mL: EMS
• RPC4046: Celgene
• OC000459: Oxagen Ltd
Discover more about therapies set to grab major Eosinophilic Gastroenteritis market share @ Eosinophilic Gastroenteritis Treatment Market
https://www.delveinsight.com/sample-request/eosinophilic-gastroenteritis-ege-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Eosinophilic Gastroenteritis Market Drivers
• Increasing disease burden due to increasing prevalence in the general population
• A better understanding of disease pathogenesis may lead to the identification of novel molecular targets for the treatment
Eosinophilic Gastroenteritis Market Barriers
• Lack of approved therapies indicated for EGE in the US, EU, and Japan
• Huge annual psychological, social, and economic burden (QALY), in advanced countries, due to EGE
Scope of the Eosinophilic Gastroenteritis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Eosinophilic Gastroenteritis Companies: Allakos, AstraZeneca, Invea Therapeutics, Pfizer, Ception Therapeutics, Regeneron, EsoCap AG, Celgene, Allakos Inc., Ellodi Pharma, Takeda, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Novartis, EMS, Celgene, Oxagen Ltd, and others
• Key Eosinophilic Gastroenteritis Therapies: Lirentelimab, Benralizumab, INVA8001, Etrasimod, reslizumab, Dupilumab, ESO-101, CC-93538, AK002, APT-1011, budesonide, Mesalamine, IRL201104, QAX576, Florence 30 μg/mL, RPC4046, OC000459, and others
• Eosinophilic Gastroenteritis Therapeutic Assessment: Eosinophilic Gastroenteritis current marketed and Eosinophilic Gastroenteritis emerging therapies
• Eosinophilic Gastroenteritis Market Dynamics: Eosinophilic Gastroenteritis market drivers and Eosinophilic Gastroenteritis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Eosinophilic Gastroenteritis Unmet Needs, KOL's views, Analyst's views, Eosinophilic Gastroenteritis Market Access and Reimbursement
To know more about Eosinophilic Gastroenteritis companies working in the treatment market, visit @ Eosinophilic Gastroenteritis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/eosinophilic-gastroenteritis-ege-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Eosinophilic Gastroenteritis Market Report Introduction
2. Executive Summary for Eosinophilic Gastroenteritis
3. SWOT analysis of Eosinophilic Gastroenteritis
4. Eosinophilic Gastroenteritis Patient Share (%) Overview at a Glance
5. Eosinophilic Gastroenteritis Market Overview at a Glance
6. Eosinophilic Gastroenteritis Disease Background and Overview
7. Eosinophilic Gastroenteritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Eosinophilic Gastroenteritis
9. Eosinophilic Gastroenteritis Current Treatment and Medical Practices
10. Eosinophilic Gastroenteritis Unmet Needs
11. Eosinophilic Gastroenteritis Emerging Therapies
12. Eosinophilic Gastroenteritis Market Outlook
13. Country-Wise Eosinophilic Gastroenteritis Market Analysis (2019-2032)
14. Eosinophilic Gastroenteritis Market Access and Reimbursement of Therapies
15. Eosinophilic Gastroenteritis Market Drivers
16. Eosinophilic Gastroenteritis Market Barriers
17. Eosinophilic Gastroenteritis Appendix
18. Eosinophilic Gastroenteritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Eosinophilic Gastroenteritis Epidemiology https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Eosinophilic Gastroenteritis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Eosinophilic Gastroenteritis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.
Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.
Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eosinophilic Gastroenteritis Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | Novartis, Allakos, AstraZeneca, Pfizer, Regeneron, Celgene here
News-ID: 3423453 • Views: …
More Releases from DelveInsight Business Research
Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining …
DelveInsight's newly released report, "Geographic Atrophy Pipeline Insight" offers a comprehensive analysis of the evolving Geographic Atrophy (GA) therapeutic landscape, covering 23+ biopharmaceutical companies and 25 investigational drug candidates. The report features in-depth profiles of both clinical- and preclinical-stage assets, along with a detailed therapeutic assessment categorized by product type, development phase, route of administration, and molecular class. It also provides visibility into inactive and discontinued pipeline programs within the…
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies …
DelveInsight, a prominent market intelligence and consulting organization in the life sciences domain, has announced the launch of its newest report titled "Interstitial Lung Disease Pipeline Insight, 2025." The publication delivers a comprehensive analysis of the fast-advancing therapeutic environment for Interstitial Lung Disease (ILD). With over 120 biopharmaceutical companies actively developing 120+ pipeline assets, the ILD pipeline is witnessing remarkable growth fueled by strong scientific innovation, clinical progress, and regulatory…
Global Vein Illumination Devices Market Forecast to Reach USD 152.83 Million by …
DelveInsight's latest publication, "Vein Illumination Devices Market Insights, Competitive Landscape and Market Forecast-2032," offers a comprehensive analysis of existing and future market dynamics. The report examines evolving trends, technological advancements, key market challenges, growth catalysts, and limiting factors, while also showcasing upcoming product launches and profiling the major players influencing the vein illumination devices industry.
Based on DelveInsight's most recent evaluation, the global vein illumination devices market is anticipated to experience…
Liver Cancer Clinical Trial Analysis: 75+ Drugs, 70+ Companies Redefining the Fu …
DelveInsight's "Liver Cancer Pipeline Insights 2025" delivers an in-depth overview of the liver cancer pipeline ecosystem, profiling more than 70 companies and 75+ therapeutic candidates under development. The report thoroughly examines liver cancer drug profiles across both clinical and preclinical stages. It also evaluates the therapeutic landscape by product category, development phase, route of administration, and molecular class, while additionally identifying inactive and discontinued assets within the pipeline.
Stay informed with…
More Releases for Eosinophilic
Eosinophilic Esophagitis Market to Surge to USD 4.1 Billion by 2034
Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, characterized by eosinophil infiltration, difficulty swallowing, food impaction, and chest pain. Once considered rare, EoE has now emerged as one of the most common causes of dysphagia in children and adults, particularly in developed nations. Strong associations with allergic conditions such as asthma, eczema, and food allergies underscore its complex immunological nature.
Download Full PDF Sample Copy of Market…
Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2030
The eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Esophagitis Pipeline, Clinical Trials Assessment, Emerging Therapie …
DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Eosinophilic Esophagitis research. Learn more about…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Granulomatosis Treatment Market Size and Overview Upto 2028|
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Eosinophilic Granulomatosis Treatment market. It includes Porter's Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Eosinophilic Granulomatosis Treatment Market. We have provided a deep analysis of the vendor landscape to give…
